Neoadjuvant lutetium PSMA, the TIME and immune response in high-risk localized prostate cancer
Renu Eapen, Scott Williams, Sean Macdonald, Simon P. Keam, Nathan Lawrentschuk, Lewis Au, Michael S. Hofman, Declan G. Murphy, Paul J. Neeson
Topics & Concepts
MedicineProstate cancerLutetiumOncologyProstateInternal medicineCancerRadiation therapyImmunogenic cell deathImmune systemCancer researchImmunotherapyImmunologyYttriumOxideOrganic chemistryChemistryProstate Cancer Treatment and ResearchImmunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers